- Price
- $96.74
- Day
- -0.47%
- Mkt Cap
- $123.43B
- 52W Range
- $69.51 – $110.68
- Volume
- 4.48M
- Beta
- 0.58
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?
Read full article
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read full article
Appointments can be scheduled through the CVS Health app or CVS.com and walk-ins are accepted WOONSOCKET, R.I., Sept. 3, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that updated 2026-2027 COVID-19 vaccines are now available at CVS Pharmacy® and MinuteClinic® locations for patients at no-cost with most insurance plans.
Read full article
CVS Health's strong cash generation, higher operating cash flow outlook and disciplined capital deployment support continued deleveraging in 2026.
Read full article
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Read full article
Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, Sept. 2,
Read full article
CVS was called a "top pick" by one Wall Street analyst. The healthcare giant's recovery is gaining traction.
Read full article
UnitedHealth Group's stronger six-month return, improving UnitedHealthcare and Optum results and attractive valuation make it the better buy.
Read full article
CVS reported triple-digit earnings growth in the second quarter. The company also upgraded its yearly guidance.
Read full article
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read full article
Both CVS and Intel delivered real turnaround results in 2026, then both stocks got punished for very different reasons. For a retiree drawing income from a portfolio, one of those reasons matters far more than the other.
Read full article
CVS Health carries strong pharmacy momentum into H2 2026, with rising prescription volume, Rite Aid gains and higher profit.
Read full article